Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim
Clinical trial NCT00206713 · TERMINATED
Trial details
- NCT number
- NCT00206713
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2006-10-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.